De-prioritized assets already registered in Europe/ex-Europe
Novel launch assets not yet registered in Europe; EU license holders
Novel launch assets not yet registered in Europe; EU license holders
Overview of EBT’s comprehensive services:
- Product launch planning and execution
- Promotional and marketing activities to create market awareness
- Medical affairs and KOL management to engage healthcare professionals
- Supply chain distribution and fulfilment to ensure product availability
- Pharmacovigilance and regulatory compliance to adhere to all requirement
- Pricing and reimbursement strategies for optimal market access
- Full commercialization support to maximize asset value across Europe
Supply Management
Through close collaboration with local stakeholders and well-established distribution networks, EBT safeguards the availability of assets while minimizing the impact of supply risk
Compliance/Pharmacovigilance
EBT ensures full compliance with pharmacovigilance and/or stipulated RMP’s as outlined by regulatory authorities
- Providing deep regional & market knowledge coupled with solid therapeutic launch experience
- Minimizing the time and resources needed to invest in a transaction
- Providing flexibility on deal structure: acquisition, licensing or co-promotion
- Offering exclusive product focus resulting in near-and long-term result
- Safeguarding against commercial, medical, legal and reputational risk
- Advancement of company reputation through ethical and compliant communication/partnership with:
- Regulators and reimbursement authorities
- KOL’s/physicians and patients/patient organizations
- Policymakers and professional societies, etc.
- Commitment to expanding access to innovation in developing countries through several channels:
- Regulatory approval and national reimbursement
- Named-patient and compassionate use/donation program (as appropriate)
- Comprehensive diagnostic testing support program & diagnostic company partnerships
- Shared financial upside
- Potential to leverage our digital infrastructure for partnerships on additional products
- Opportunity to establish permanent footprint in specific markets (or regions)
